Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Advances in Therapy|September 14, 2024
The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficileAntoine Boustany, Paul Feuerstadt, Glenn TillotsonFrontiers in Medicine|January 26, 2023
Gut microbiota and microbiota-based therapies for Clostridioides difficile infectionTeena Chopra, Gail Hecht, Glenn TillotsonExpert Review of Anti-Infective Therapy|July 6, 2026
The changing picture of community acquired urinary tract infections in the US: a daunting prospectTeena Chopra, Glenn Tillotson, Angela DonaldFrontiers in Pharmacology|May 13, 2022
The Practical Problem With Carbapenem Testing and Reporting Accurate Bacterial SusceptibilitiesMark Redell, Glenn S TillotsonMicroorganisms|November 27, 2025
Fecal Microbiota Transplantation in Animals: Therapeutics, Conservation, and FarmingKelly R Reveles, Joni Meehan, Glenn TillotsonAllergy and Asthma Proceedings|October 23, 2010
The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007Marya D Zilberberg, Thomas Jacobsen, Glenn TillotsonExpert Review of Anti-Infective Therapy|August 21, 2020
Global travel and Gram-negative bacterial resistance; implications on clinical managementNicolette Theriault, Glenn Tillotson, Christian E SandrockTherapeutic Advances in Gastroenterology|March 7, 2022
Transitions of care in Clostridioides difficile infection: a need of the hourSahil Khanna, James Lett, Cheri Lattimer, et al.Journal of Medical Economics|May 20, 2009
Assessing the economic merits of managing cytomegalovirus infection in organ and stem cell transplantationSuzanne Wait, Primrose Musingarimi, Andrew Briggs, et al.Open Forum Infectious Diseases|March 19, 2021
Heterogeneity of Recent Phase 3 Complicated Urinary Tract Infection Clinical TrialsSimon Portsmouth, Almasa Bass, Roger Echols, et al.Pageof 6